1	Enhanced	Enhance	B-NP	VBN	O	3	NMOD	17	Enhanced
2	IGF-1	IGF-1	I-NP	NN	B-protein	3	NMOD	0
3	expression	expression	I-NP	NN	O	4	SUB	9	expression
4	improves	improve	B-VP	VBZ	O	0	ROOT	17	improves
5	smooth	smooth	B-NP	JJ	O	8	NMOD	0
6	muscle	muscle	I-NP	NN	O	8	NMOD	0
7	cell	cell	I-NP	NN	O	8	NMOD	0
8	engraftment	engraftment	I-NP	NN	O	4	OBJ	2	engraftment
9	after	after	B-PP	IN	O	4	VMOD	0
10	cell	cell	B-NP	NN	O	11	NMOD	0
11	transplantation	transplantation	I-NP	NN	O	9	PMOD	19	transplantation
12	.	.	O	.	O	4	P	0

1	The	The	B-NP	DT	O	3	NMOD	0
2	functional	functional	I-NP	JJ	O	3	NMOD	0
3	benefit	benefit	I-NP	NN	O	11	SUB	0
4	of	of	B-PP	IN	O	3	NMOD	0
5	cell	cell	B-NP	NN	O	6	NMOD	0
6	transplantation	transplantation	I-NP	NN	O	4	PMOD	19	transplantation
7	after	after	B-PP	IN	O	3	NMOD	0
8	a	a	B-NP	DT	O	10	NMOD	0
9	myocardial	myocardial	I-NP	JJ	O	10	NMOD	0
10	infarction	infarction	I-NP	NN	O	7	PMOD	0
11	is	be	B-VP	VBZ	O	0	ROOT	0
12	diminished	diminish	I-VP	VBN	O	11	VC	0
13	by	by	B-PP	IN	O	12	VMOD	0
14	early	early	B-NP	JJ	O	16	NMOD	0
15	cell	cell	I-NP	NN	O	16	NMOD	0
16	losses	loss	I-NP	NNS	O	13	PMOD	5	losses
17	.	.	O	.	O	11	P	0

1	IGF-1	IGF-1	B-NP	NN	B-protein	2	SUB	0
2	enhances	enhance	B-VP	VBZ	O	0	ROOT	17	enhances
3	cell	cell	B-NP	NN	O	2	OBJ	0
4	proliferation	proliferation	I-NP	NN	O	3	NMOD	1	proliferation
5	and	and	I-NP	CC	O	3	NMOD	0
6	survival	survival	I-NP	NN	O	3	NMOD	5	survival
7	.	.	O	.	O	2	P	0

1	We	We	B-NP	PRP	O	2	SUB	0
2	hypothesized	hypothesize	B-VP	VBD	O	0	ROOT	0
3	that	that	B-SBAR	IN	O	2	VMOD	0
4	IGF-1-transfected	IGF-1-transfected	B-NP	JJ	B-cell_type	7	NMOD	19	transfected
5	smooth	smooth	I-NP	JJ	I-cell_type	7	NMOD	0
6	muscle	muscle	I-NP	NN	I-cell_type	7	NMOD	0
7	cells	cell	I-NP	NNS	I-cell_type	11	SUB	0
8	(	(	O	(	O	10	DEP	0
9	SMCs	SMC	B-NP	NNS	B-cell_type	10	DEP	0
10	)	)	O	)	O	7	NMOD	0
11	would	would	B-VP	MD	O	3	SBAR	0
12	enhance	enhance	I-VP	VB	O	11	VC	17	enhance
13	cell	cell	B-NP	NN	O	14	NMOD	0
14	survival	survival	I-NP	NN	O	12	OBJ	5	survival
15	and	and	O	CC	O	12	VMOD	0
16	improve	improve	B-VP	VB	O	12	VMOD	17	improve
17	engraftment	engraftment	B-NP	NN	O	16	OBJ	2	engraftment
18	after	after	B-PP	IN	O	16	VMOD	0
19	cell	cell	B-NP	NN	O	20	NMOD	0
20	transplantation	transplantation	I-NP	NN	O	18	PMOD	19	transplantation
21	.	.	O	.	O	2	P	0

1	The	The	B-NP	DT	O	3	NMOD	0
2	IGF-1	IGF-1	I-NP	NN	B-DNA	3	NMOD	0
3	gene	gene	I-NP	NN	I-DNA	4	SUB	0
4	was	be	B-VP	VBD	O	0	ROOT	0
5	transfected	transfecte	I-VP	VBN	O	4	VC	19	transfected
6	into	into	B-PP	IN	O	5	VMOD	0
7	male	male	B-NP	JJ	B-cell_type	8	NMOD	0
8	SMCs	SMC	I-NP	NNS	I-cell_type	6	PMOD	0
9	and	and	O	CC	O	5	VMOD	0
10	compared	compare	B-PP	VBN	O	5	VMOD	0
11	with	with	B-PP	IN	O	10	PMOD	0
12	SMCs	SMC	B-NP	NNS	B-cell_type	11	PMOD	0
13	transfected	transfecte	B-VP	VBN	O	12	NMOD	19	transfected
14	with	with	B-PP	IN	O	13	VMOD	0
15	a	a	B-NP	DT	O	17	NMOD	0
16	plasmid	plasmid	I-NP	NN	O	17	NMOD	0
17	vector	vector	I-NP	NN	O	24	NMOD	0
18	(	(	O	(	O	21	DEP	0
19	vector	vector	B-NP	NN	O	20	NMOD	0
20	control	control	I-NP	NN	O	21	DEP	0
21	)	)	O	)	O	17	NMOD	0
22	and	and	O	CC	O	24	NMOD	0
23	nontransfected	nontransfected	B-NP	JJ	B-cell_type	24	NMOD	19	nontransfected
24	SMCs	SMC	I-NP	NNS	I-cell_type	14	PMOD	0
25	(	(	O	(	O	28	DEP	0
26	cell	cell	B-NP	NN	O	27	NMOD	0
27	control	control	I-NP	NN	O	28	DEP	0
28	)	)	O	)	O	24	NMOD	0
29	.	.	O	.	O	4	P	0

1	IGF-1	IGF-1	B-NP	NN	B-RNA	2	NMOD	0
2	mRNA	mRNA	I-NP	NN	I-RNA	8	NMOD	0
3	(	(	O	(	O	5	DEP	0
4	n=10/group	n=10/group	B-NP	NN	O	5	DEP	0
5	)	)	O	)	O	2	NMOD	0
6	and	and	O	CC	O	8	NMOD	0
7	protein	protein	B-NP	NN	O	8	NMOD	0
8	levels	level	I-NP	NNS	O	12	SUB	0
9	(	(	O	(	O	11	DEP	0
10	n=6/group	n=6/group	B-NP	NN	O	11	DEP	0
11	)	)	O	)	O	8	NMOD	0
12	were	be	B-VP	VBD	O	0	ROOT	0
13	higher	high	B-ADJP	JJR	O	12	PRD	0
14	(	(	O	(	O	22	DEP	0
15	P	P	B-NP	NN	O	22	DEP	0
16	less	less	B-ADJP	JJR	O	15	NMOD	0
17	than	than	B-PP	IN	O	16	AMOD	0
18	0.05	0.05	B-NP	CD	O	17	PMOD	0
19	for	for	B-PP	IN	O	18	NMOD	0
20	all	all	B-NP	DT	O	21	NMOD	0
21	groups	group	I-NP	NNS	O	19	PMOD	0
22	)	)	O	)	O	13	AMOD	0
23	at	at	B-PP	IN	O	13	AMOD	0
24	3	3	B-NP	CD	O	30	NMOD	0
25	,	,	I-NP	,	O	30	P	0
26	7	7	I-NP	CD	O	30	NMOD	0
27	,	,	O	,	O	30	P	0
28	and	and	O	CC	O	30	NMOD	0
29	14	14	B-NP	CD	O	30	NMOD	0
30	days	day	I-NP	NNS	O	23	PMOD	0
31	compared	compare	B-PP	VBN	O	23	PMOD	0
32	with	with	B-PP	IN	O	31	PMOD	0
33	controls	control	B-NP	NNS	O	32	PMOD	0
34	.	.	O	.	O	12	P	0

1	VEGF	VEGF	B-NP	NN	B-protein	2	SUB	0
2	was	be	B-VP	VBD	O	0	ROOT	0
3	also	also	I-VP	RB	O	2	VMOD	0
4	increased	increase	I-VP	VBN	O	2	VC	17	increased
5	in	in	B-PP	IN	O	4	VMOD	0
6	parallel	parallel	B-NP	NN	O	5	PMOD	0
7	to	to	B-PP	TO	O	6	NMOD	0
8	enhanced	enhance	B-NP	VBN	O	10	NMOD	17	enhanced
9	IGF-1	IGF-1	I-NP	NN	B-protein	10	NMOD	0
10	expression	expression	I-NP	NN	O	7	PMOD	9	expression
11	.	.	O	.	O	2	P	0

1	IGF-1-transfected	IGF-1-transfected	B-NP	JJ	B-cell_line	2	NMOD	19	transfected
2	cells	cell	I-NP	NNS	I-cell_line	3	SUB	0
3	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	0
4	greater	great	B-NP	JJR	O	6	NMOD	0
5	cell	cell	I-NP	NN	O	6	NMOD	0
6	proliferation	proliferation	I-NP	NN	O	3	OBJ	1	proliferation
7	,	,	O	,	O	6	P	0
8	stimulated	stimulate	B-VP	VBN	O	6	NMOD	17	stimulated
9	angiogenesis	angiogenesis	B-NP	NN	O	8	VMOD	3	angiogenesis
10	,	,	O	,	O	3	P	0
11	and	and	O	CC	O	3	VMOD	0
12	decreased	decrease	B-VP	VBD	O	3	VMOD	18	decreased
13	caspase-3	caspase-3	B-NP	NN	B-protein	14	NMOD	0
14	activity	activity	I-NP	NN	O	12	OBJ	0
15	after	after	B-PP	IN	O	12	VMOD	0
16	simulated	simulated	B-NP	JJ	O	17	NMOD	0
17	ischemia	ischemia	I-NP	NN	O	19	NMOD	0
18	and	and	O	CC	O	19	NMOD	0
19	reperfusion	reperfusion	B-NP	NN	O	15	PMOD	0
20	(	(	O	(	O	34	DEP	0
21	P	P	B-NP	NN	O	34	DEP	0
22	less	less	B-ADJP	JJR	O	21	NMOD	0
23	than	than	B-PP	IN	O	22	AMOD	0
24	0.05	0.05	B-NP	CD	O	23	PMOD	0
25	for	for	B-PP	IN	O	24	NMOD	0
26	all	all	B-NP	DT	O	27	NMOD	0
27	groups	group	I-NP	NNS	O	25	PMOD	0
28	compared	compare	B-PP	VBN	O	21	NMOD	0
29	with	with	B-PP	IN	O	28	PMOD	0
30	vector	vector	B-NP	NN	O	33	NMOD	0
31	or	or	I-NP	CC	O	33	NMOD	0
32	cell	cell	I-NP	NN	O	33	NMOD	0
33	controls	control	I-NP	NNS	O	29	PMOD	0
34	)	)	O	)	O	19	NMOD	0
35	.	.	O	.	O	3	P	0

1	A	A	B-NP	DT	O	5	NMOD	0
2	uniform	uniform	I-NP	JJ	O	5	NMOD	0
3	left	left	I-NP	JJ	O	5	NMOD	0
4	ventricular	ventricular	I-NP	JJ	O	5	NMOD	0
5	injury	injury	I-NP	NN	O	6	SUB	0
6	was	be	B-VP	VBD	O	0	ROOT	0
7	produced	produce	I-VP	VBN	O	6	VC	0
8	in	in	B-PP	IN	O	7	VMOD	0
9	female	female	B-NP	JJ	O	10	NMOD	0
10	rats	rat	I-NP	NNS	O	8	PMOD	0
11	using	use	B-VP	VBG	O	6	VMOD	0
12	a	a	B-NP	DT	O	13	NMOD	0
13	cryoprobe	cryoprobe	I-NP	NN	O	11	OBJ	0
14	.	.	O	.	O	6	P	0

1	Three	Three	B-NP	CD	O	2	NMOD	0
2	weeks	week	I-NP	NNS	O	0	ROOT	0
3	later	later	B-ADVP	RB	O	2	VMOD	0
4	,	,	O	,	O	3	AMOD	0
5	2	2	B-NP	CD	O	7	NMOD	0
6	x	x	I-NP	CC	O	7	NMOD	0
7	10	10	I-NP	CD	O	4	OBJ	0
8	(	(	O	(	O	7	NMOD	0
9	6	6	B-NP	CD	O	11	NMOD	0
10	)	)	O	)	O	11	NMOD	0
11	cells	cell	B-NP	NNS	O	15	SUB	0
12	from	from	B-PP	IN	O	11	NMOD	0
13	three	three	B-NP	CD	O	14	NMOD	0
14	groups	group	I-NP	NNS	O	12	PMOD	0
15	were	be	B-VP	VBD	O	8	SBAR	0
16	implanted	implant	I-VP	VBN	O	15	VC	19	implanted
17	into	into	B-PP	IN	O	16	VMOD	0
18	the	the	B-NP	DT	O	19	NMOD	0
19	scar	scar	I-NP	NN	O	17	PMOD	0
20	.	.	O	.	O	2	P	0

1	One	One	B-NP	CD	O	2	NMOD	0
2	week	week	I-NP	NN	O	7	SUB	0
3	later	later	B-ADVP	RB	O	7	VMOD	0
4	,	,	O	,	O	7	P	0
5	IGF-1-transfected	IGF-1-transfected	B-NP	JJ	B-protein	6	NMOD	19	transfected
6	SMCs	SMC	I-NP	NNS	I-protein	7	SUB	0
7	had	have	B-VP	VBD	O	0	ROOT	0
8	increased	increase	I-VP	VBN	O	13	NMOD	17	increased
9	myocardial	myocardial	B-NP	JJ	O	13	NMOD	0
10	IGF-1	IGF-1	I-NP	NN	B-protein	13	NMOD	0
11	and	and	I-NP	CC	O	13	NMOD	0
12	VEGF	VEGF	I-NP	NN	B-protein	13	NMOD	0
13	levels	level	I-NP	NNS	O	26	NMOD	0
14	,	,	O	,	O	26	P	0
15	increased	increase	B-NP	VBN	O	17	NMOD	17	increased
16	Bcl2	Bcl2	I-NP	NN	B-protein	17	NMOD	0
17	expression	expression	I-NP	NN	O	26	NMOD	9	expression
18	,	,	O	,	O	26	P	0
19	limited	limited	B-NP	JJ	O	21	NMOD	18	limited
20	cell	cell	I-NP	NN	O	21	NMOD	0
21	apoptosis	apoptosis	I-NP	NN	O	26	NMOD	5	apoptosis
22	,	,	O	,	O	26	P	0
23	and	and	O	CC	O	26	NMOD	0
24	enhanced	enhance	B-NP	VBN	O	26	NMOD	17	enhanced
25	vessel	vessel	I-NP	NN	O	26	NMOD	0
26	formation	formation	I-NP	NN	O	7	OBJ	2	formation
27	in	in	B-PP	IN	O	26	NMOD	0
28	the	the	B-NP	DT	O	30	NMOD	0
29	myocardial	myocardial	I-NP	JJ	O	30	NMOD	0
30	scar	scar	I-NP	NN	O	27	PMOD	0
31	compared	compare	B-PP	VBN	O	7	VMOD	0
32	with	with	B-PP	IN	O	31	PMOD	0
33	the	the	B-NP	DT	O	36	NMOD	0
34	two	two	I-NP	CD	O	36	NMOD	0
35	control	control	I-NP	NN	O	36	NMOD	0
36	groups	group	I-NP	NNS	O	32	PMOD	0
37	(	(	O	(	O	45	DEP	0
38	P	P	B-NP	NN	O	45	DEP	0
39	less	less	B-ADJP	JJR	O	38	NMOD	0
40	than	than	B-PP	IN	O	39	AMOD	0
41	0.05	0.05	B-NP	CD	O	40	PMOD	0
42	for	for	B-PP	IN	O	41	NMOD	0
43	all	all	B-NP	DT	O	44	NMOD	0
44	groups	group	I-NP	NNS	O	42	PMOD	0
45	)	)	O	)	O	36	NMOD	0
46	.	.	O	.	O	7	P	0

1	The	The	B-NP	DT	O	2	NMOD	0
2	proportion	proportion	I-NP	NN	O	10	SUB	0
3	of	of	B-PP	IN	O	2	NMOD	0
4	SMCs	SMC	B-NP	NNS	B-cell_type	3	PMOD	0
5	surviving	survive	B-VP	VBG	O	2	NMOD	5	surviving
6	in	in	B-PP	IN	O	5	VMOD	0
7	the	the	B-NP	DT	O	9	NMOD	0
8	implanted	implant	I-NP	VBN	O	9	NMOD	19	implanted
9	region	region	I-NP	NN	O	6	PMOD	0
10	was	be	B-VP	VBD	O	0	ROOT	0
11	greater	great	B-ADJP	JJR	O	10	PRD	0
12	(	(	O	(	O	17	DEP	0
13	P	P	B-NP	NN	O	15	SUB	0
14	less	less	B-ADJP	JJR	O	15	AMOD	0
15	than	than	B-PP	IN	O	17	DEP	0
16	0.05	0.05	B-NP	CD	O	15	AMOD	0
17	)	)	O	)	O	11	AMOD	0
18	in	in	B-PP	IN	O	10	VMOD	0
19	the	the	B-NP	DT	O	21	NMOD	0
20	IGF-1-transfected	IGF-1-transfected	I-NP	JJ	O	21	NMOD	19	transfected
21	group	group	I-NP	NN	O	18	PMOD	0
22	than	than	B-PP	IN	O	10	VMOD	0
23	in	in	B-PP	IN	O	22	PMOD	0
24	the	the	B-NP	DT	O	28	NMOD	0
25	vector	vector	I-NP	NN	O	28	NMOD	0
26	or	or	I-NP	CC	O	28	NMOD	0
27	cell	cell	I-NP	NN	O	28	NMOD	0
28	controls	control	I-NP	NNS	O	23	PMOD	0
29	.	.	O	.	O	10	P	0

1	Gene	Gene	B-NP	NN	O	2	NMOD	0
2	enhancement	enhancement	I-NP	NN	O	5	SUB	17	enhancement
3	with	with	B-PP	IN	O	2	NMOD	0
4	IGF-1	IGF-1	B-NP	NN	B-protein	3	PMOD	0
5	improved	improve	B-VP	VBD	O	0	ROOT	17	improved
6	donor	donor	B-NP	NN	O	8	NMOD	0
7	cell	cell	I-NP	NN	O	8	NMOD	0
8	proliferation	proliferation	I-NP	NN	O	13	NMOD	1	proliferation
9	,	,	O	,	O	13	P	0
10	survival	survival	B-NP	NN	O	13	NMOD	5	survival
11	,	,	O	,	O	13	P	0
12	and	and	O	CC	O	13	NMOD	0
13	engraftment	engraftment	B-NP	NN	O	5	OBJ	2	engraftment
14	after	after	B-PP	IN	O	13	NMOD	0
15	cell	cell	B-NP	NN	O	16	NMOD	0
16	transplantation	transplantation	I-NP	NN	O	14	PMOD	19	transplantation
17	,	,	O	,	O	5	P	0
18	perhaps	perhaps	B-VP	RB	O	19	VMOD	0
19	mediated	mediate	I-VP	VBN	O	5	VMOD	0
20	by	by	B-PP	IN	O	19	VMOD	0
21	enhanced	enhance	B-NP	VBN	O	22	NMOD	17	enhanced
22	angiogenesis	angiogenesis	I-NP	NN	O	25	NMOD	3	angiogenesis
23	and	and	O	CC	O	25	NMOD	0
24	reduced	reduce	B-NP	VBN	O	25	NMOD	0
25	apoptosis	apoptosis	I-NP	NN	O	20	PMOD	0
26	.	.	O	.	O	5	P	0

